Taking into account that IL6 was found to be elevated in obese individuals, but also in the setting of type 2 diabetes mellitus and insulin resistance [117], we might emphasize that this interleukin could represent a ‘bridge’ between obesity and obesity-related systemic complications. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.